SNOA - Sonoma Pharmaceuticals, Inc.
2.606
-0.194 -7.444%
Share volume: 47,098
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$2.80
-0.19
-0.07%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
| Report Date | 01-07-2025 | 08-08-2024 | 11-07-2024 | 02-05-2025 | 06-17-2025 | 08-07-2025 | 11-04-2025 | 02-10-2026 | |
| Total revenue | 3.439 M | 3.391 M | 3.579 M | 3.564 M | 3.754 M | 4.015 M | 5.604 M | 4.349 M | |
| Cost of revenue | 2.348 M | 2.085 M | 2.218 M | 2.294 M | 2.226 M | 2.551 M | 3.484 M | 2.699 M | |
| Gross profit | 1.091 M | 1.306 M | 1.361 M | 1.270 M | 1.528 M | 1.464 M | 2.120 M | 1.650 M | |
| 19.71% | 4.21% | -6.69% | 20.31% | -4.19% | 44.81% | -22.17% | |||
| Operating expenses | 2.500 M | 2.479 M | 2.211 M | 2.301 M | 2.184 M | 2.559 M | 2.457 M | 2.328 M | |
| Selling general and admin | 2.091 M | 2.009 M | 1.705 M | 1.874 M | 1.773 M | 1.965 M | 1.882 M | 1.771 M | |
| Research and development | 409.000 K | 470.000 K | 506.000 K | 427.000 K | 411.000 K | 594.000 K | 575.000 K | 557.000 K | |
| Total expenses | 2.500 M | 2.479 M | 2.211 M | 2.301 M | 2.184 M | 2.559 M | 2.457 M | 2.328 M | |
| -0.84% | -10.81% | 4.07% | -5.08% | 17.17% | -3.99% | -5.25% | |||
| Operating income | -1.409 M | -1.173 M | -850.000 K | -1.031 M | -656.000 K | -1.095 M | -337.000 K | -678.000 K | |
| Ebit | -1.359 M | -997.000 K | -463.000 K | -919.000 K | -528.000 K | -1.242 M | -731.000 K | -949.000 K | |
| Pretax income | -1.359 M | -997.000 K | -463.000 K | -919.000 K | -528.000 K | -1.242 M | -731.000 K | -949.000 K | |
| -26.64% | -53.56% | 98.49% | -42.55% | 135.23% | -41.14% | 29.82% | |||
| Income tax | -292.000 K | 146.000 K | 147.000 K | 9.000 K | 248.000 K | -1.000 K | -197.000 K | -130.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.067 M | -1.143 M | -610.000 K | -928.000 K | -776.000 K | -1.241 M | -534.000 K | -819.000 K | |
| -7.12% | 46.63% | -52.13% | 16.38% | -59.92% | 56.97% | -53.37% |